Skip to main content

Table 2 Contact coverage among all diagnosed with 12-mo MDD (N = 491), according to MDD clinical severity; Sao Paulo Metropolitan Area, Brazil

From: Towards measuring effective coverage: critical bottlenecks in quality- and user-adjusted coverage for major depressive disorder in São Paulo metropolitan area, Brazil

 

12-mo DSM-IV MDD

F (p-value)

Severe (n = 224)

Mild/moderate (n = 265)

Any severity (n = 489)a

n

% (SE)

n

% (SE)

n

% (SE)

Contact coverage

90

42.1 (3.8)

74

26.6 (3.1)

164

33.3 (1.9)

7.00 (0.014)*

Any psychotropic medication

79

37.2 (4.4)

47

17.8 (2.5)

126#

26.1 (2.3)

13.99 (< .001)*

Any antidepressants

52

21.8 (3.8)

32

12.7 (2.3)

84#

16.6 (2.2)

5.35 (0.029)*

Adequate medication control

43

20.2 (3.0)

21

10.0 (1.9)

64

14.3 (1.9)

10.26 (0.004)*

Adequate pharmacotherapy

25

11.1 (2.6)

12

6.1 (1.9)

37

8.3 (1.7)

3.08 (0.09)

Any psychotherapy

39

19.9 (2.9)

22

8.8 (1.6)

61

13.5 (1.9)

22.57 (< 0.001)*

Adequate psychotherapy

30

14.9 (2.4)

19

8.2 (1.6)

49

11.1 (1.7)

10.04 (0.004)*

Effective coverage

13

7.3 (1.8)

22

9.2 (1.8)

35

8.4 (1.5)

0.92 (0.35)

  1. MDD, major depressive disorder; SE, standard error
  2. Unweighted numbers (n) and weighted percentages (%) are shown
  3. *Significant at the 0.05 level, two-sided test
  4. aTwo 12-mo MDD cases were exclude due to lack of information regarding service use
  5. #Eleven respondents were in use of medication without a 12-month prescription
Back to article page

International Journal of Mental Health Systems

ISSN: 1752-4458